Company Overview: ATHA Energy Corp. (TSXV: SASK) is a Canadian mineral exploration company focused on the acquisition, exploration, and development of uranium assets. The Company’s strategic objective is to advance its uranium projects to support the growing demand for clean, sustainable energy solutions in the transition to a low-carbon future. Century Therapeutics Inc. (NASDAQ: IPSC) is a biotechnology company focused on developing transformative allogeneic cell therapies for the treatment of both solid tumors and hematological malignancies. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

As of July 24, 2025, major U.S. equity indices recorded positive week-to-date (WTD) performances, supported by broad-based sector strength. The S&P 500 edged up 0.85% to close at 6,363.35, while the NASDAQ Composite advanced 1.51% to 21,057.96, driven by sustained momentum in the technology sector. The Russell 2000, which tracks small-cap stocks, also posted gains, rising 0.54% to finish the week at 2,252.13.

In Canada, the S&P/TSX Venture Composite Index advanced 0.65% week-to-date (WTD) to close at 802.93, extending its broader uptrend. Thursday’s session saw notable strength across the technology, financials, real estate, and energy sectors, providing near-term support and reinforcing pockets of bullish momentum. However, these gains were partially offset by continued weakness in industrials, consumer cyclicals, consumer non-cyclicals, basic materials, and healthcare. This sectoral divergence highlights ongoing investor caution, which is tempering the broader rally and signalling a selective risk-on approach despite the index’s recent resilience.